SCHEMBL30633362

SCHEMBL30633362

Nc1n[nH]c2ccc(-c3ccnc(NC(=O)Nc4ccccc4C(=O)Nc4ccccc4)c3)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 12/20 0.53
▸ JAK1 P23458 8/20 0.53
▸ KDR P35968 2/20 0.47
▸ MAPK1 P28482 1/20 0.46
▸ CNR1 P21554 1/20 0.45
▸ CDK1 P06493 2/20 0.45
▸ CDK2 P24941 2/20 0.45
▸ MARK3 P27448 2/20 0.45
▸ GSK3B P49841 2/20 0.45
▸ CDK5 Q00535 2/20 0.45
▸ DYRK1A Q13627 2/20 0.45
▸ MARK2 Q7KZI7 2/20 0.45
▸ DYRK3 O43781 1/20 0.45
▸ MAP4K4 O95819 1/20 0.45
▸ CLK2 P49760 1/20 0.45
▸ CSNK2A1 P68400 1/20 0.45
▸ CSNK1G2 P78368 1/20 0.45
▸ MAP4K2 Q12851 1/20 0.45
▸ PRKAA1 Q13131 1/20 0.45
▸ CAMK2B Q13554 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26685861 0.90 JAK2 (0.56) JAK2JAK1KDRMAPK1CNR1
SCHEMBL30633352 0.90 JAK2 (0.56) JAK2JAK1KDRMAPK1CNR1
SCHEMBL30633312 0.89 JAK2 (0.45) JAK2JAK1MAPK1CNR1DYRK1A
SCHEMBL31420124 0.86 JAK2 (0.61) JAK2JAK1KDRMAPK1CNR1
SCHEMBL26686370 0.86 JAK2 (0.61) JAK2JAK1KDRMAPK1CNR1
SCHEMBL30633321 0.84 KDR (0.52) JAK2JAK1KDRMAPK1KIT
SCHEMBL26686360 0.84 KDR (0.52) JAK2JAK1KDRMAPK1KIT
SCHEMBL26686302 0.83 JAK2 (0.46) JAK2JAK1KDRMAPK1CDK1
SCHEMBL30633358 0.83 JAK2 (0.46) JAK2JAK1KDRMAPK1CDK1
SCHEMBL30633313 0.82 JAK2 (0.45) JAK2JAK1MAPK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback